INSIGHTS ON DRUG DEVELOPMENT

• Advancements In GLP-1 Analog Formulation: Overcoming Challenges

  Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

• Versatile Lipid Nanoparticle Platform For Efficient Gene Editing

  Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.

• Rethinking Design, Cost, And Scalability In Biomanufacturing

  Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.

• AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids

  Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.

• How To Avoid Sticking And Picking In The Tableting Industry

  9/23/2024

  Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.

• Ready To Demystify Organoids?

  7/1/2025

  Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

• From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development

  3/8/2026

  See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.

• Accelerating Clinical Development: Modern Tools In Process Chemistry

  1/23/2025

  Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

• Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery

  6/3/2025

  Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.